MOUNT LOGAN CAPITAL INC (MLCI) Fundamental Analysis & Valuation

NASDAQ:MLCI • US62188E1038

Current stock price

4.25 USD
-0.07 (-1.62%)
Last:

This MLCI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. MLCI Profitability Analysis

1.1 Basic Checks

  • In the past year MLCI was profitable.
  • MLCI had a positive operating cash flow in the past year.
MLCI Yearly Net Income VS EBIT VS OCF VS FCFMLCI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 -10M -20M -30M -40M

1.2 Ratios

  • MLCI has a better Return On Assets (5.84%) than 79.80% of its industry peers.
  • MLCI's Return On Equity of 6.21% is in line compared to the rest of the industry. MLCI outperforms 41.41% of its industry peers.
Industry RankSector Rank
ROA 5.84%
ROE 6.21%
ROIC N/A
ROA(3y)-34.26%
ROA(5y)N/A
ROE(3y)-35.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MLCI Yearly ROA, ROE, ROICMLCI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -20 -40 -60

1.3 Margins

  • The Profit Margin of MLCI (610.53%) is better than 100.00% of its industry peers.
  • The Operating Margin and Gross Margin are not available for MLCI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 610.53%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MLCI Yearly Profit, Operating, Gross MarginsMLCI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 -10K -20K -30K -40K -50K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. MLCI Health Analysis

2.1 Basic Checks

  • MLCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MLCI has about the same amout of shares outstanding than it did 1 year ago.
  • There is no outstanding debt for MLCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MLCI Yearly Shares OutstandingMLCI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2M 4M 6M 8M 10M
MLCI Yearly Total Debt VS Total AssetsMLCI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • An Altman-Z score of 8.34 indicates that MLCI is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 8.34, MLCI belongs to the top of the industry, outperforming 92.93% of the companies in the same industry.
  • MLCI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.34
ROIC/WACCN/A
WACC8.94%
MLCI Yearly LT Debt VS Equity VS FCFMLCI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 0.28 indicates that MLCI may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.28, MLCI is doing worse than 63.64% of the companies in the same industry.
  • MLCI has a Quick Ratio of 0.28. This is a bad value and indicates that MLCI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.28, MLCI is doing worse than 63.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.28
MLCI Yearly Current Assets VS Current LiabilitesMLCI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 200K 400K 600K 800K 1M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. MLCI Growth Analysis

3.1 Past

  • MLCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 117.44%, which is quite impressive.
  • Looking at the last year, MLCI shows a very strong growth in Revenue. The Revenue has grown by 265.34%.
EPS 1Y (TTM)117.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%132.69%
Revenue 1Y (TTM)265.34%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%237.22%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MLCI Yearly Revenue VS EstimatesMLCI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 50K 100K 150K

More info and screens

Find the best growth stocksShow best growing peers

2

4. MLCI Valuation Analysis

4.1 Price/Earnings Ratio

  • MLCI is valuated correctly with a Price/Earnings ratio of 14.17.
  • The rest of the industry has a similar Price/Earnings ratio as MLCI.
  • Compared to an average S&P500 Price/Earnings ratio of 27.47, MLCI is valued a bit cheaper.
Industry RankSector Rank
PE 14.17
Fwd PE N/A
MLCI Price Earnings VS Forward Price EarningsMLCI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • MLCI's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 82.07
EV/EBITDA N/A
MLCI Per share dataMLCI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. MLCI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.91%, MLCI has a reasonable but not impressive dividend return.
  • In the last 3 months the price of MLCI has falen by -46.86%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 1.82, MLCI pays a bit more dividend than its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.81, MLCI pays a better dividend.
Industry RankSector Rank
Dividend Yield 2.91%

5.2 History

  • MLCI does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
MLCI Yearly Dividends per shareMLCI Yearly Dividends per shareYearly Dividends per share 2025 2026 0.01 0.01 0.02 0.02 0.03

5.3 Sustainability

DPN/A
EPS Next 2YN/A
EPS Next 3YN/A
MLCI Yearly Income VS Free CF VS DividendMLCI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 2024 0 -10M -20M -30M -40M

More info and screens

Find the best dividend stocksShow peers with best dividend

MLCI Fundamentals: All Metrics, Ratios and Statistics

MOUNT LOGAN CAPITAL INC

NASDAQ:MLCI (4/24/2026, 10:58:16 AM)

4.25

-0.07 (-1.62%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-13
Earnings (Next)05-13
Inst Owners26.17%
Inst Owner Change0.06%
Ins Owners4%
Ins Owner Change0%
Market Cap47.60M
Revenue(TTM)488.10K
Net Income(TTM)2.98M
Analysts82.86
Price Target9.69 (128%)
Short Float %1.9%
Short Ratio2.41
Dividend
Industry RankSector Rank
Dividend Yield 2.91%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years1
Ex-Date03-30
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.17
Fwd PE N/A
P/S 97.52
P/FCF 82.07
P/OCF 82.07
P/B 0.99
P/tB 0.99
EV/EBITDA N/A
EPS(TTM)0.3
EY7.06%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.05
FCFY1.22%
OCF(TTM)0.05
OCFY1.22%
SpS0.04
BVpS4.3
TBVpS4.3
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.38693 (26.75%)
Profitability
Industry RankSector Rank
ROA 5.84%
ROE 6.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 610.53%
GM N/A
FCFM 118.83%
ROA(3y)-34.26%
ROA(5y)N/A
ROE(3y)-35.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 19.46%
Current Ratio 0.28
Quick Ratio 0.28
Altman-Z 8.34
F-Score6
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%132.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)265.34%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%237.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-96.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-79.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.07%
OCF growth 3YN/A
OCF growth 5YN/A

MOUNT LOGAN CAPITAL INC / MLCI Fundamental Analysis FAQ

What is the fundamental rating for MLCI stock?

ChartMill assigns a fundamental rating of 3 / 10 to MLCI.


Can you provide the valuation status for MOUNT LOGAN CAPITAL INC?

ChartMill assigns a valuation rating of 2 / 10 to MOUNT LOGAN CAPITAL INC (MLCI). This can be considered as Overvalued.


Can you provide the profitability details for MOUNT LOGAN CAPITAL INC?

MOUNT LOGAN CAPITAL INC (MLCI) has a profitability rating of 2 / 10.


What is the valuation of MOUNT LOGAN CAPITAL INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MOUNT LOGAN CAPITAL INC (MLCI) is 14.17 and the Price/Book (PB) ratio is 0.99.